1. The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19
   Yousef M. Hawsawi et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
2. Small molecules in the treatment of COVID-19
   Sibei Lei et al, 2022, Sig Transduct Target Ther CrossRef
3. COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
   William Danilo Fernandes de Souza et al, 2023, Cells CrossRef
4. Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
   Serafino Fazio et al, 2023, BioMed CrossRef
5. null
   Berkay Alpay et al, 2023 CrossRef
6. Renin–Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19
   Biwash Ghimire et al, 2023, Biomedicines CrossRef
7. Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique
   Mona A. Shewaiter et al, 2023, J Cancer Res Clin Oncol CrossRef
8. NSAID: Current limits to prescription
   Theo Wirth et al, 2024, Joint Bone Spine CrossRef
9. A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID‐19 patients
   Carlo Brogna et al, 2024, Journal of Medical Virology CrossRef
10. Effects of Common Anti-Inflammatories on Adenovirus Entry and Their Physicochemical Properties: An In-Depth Study Using Cellular and Animal Models
    Hector R. Galvan-Salazar et al, 2024, Microbiology Research CrossRef